July 5 (Reuters) - Tyme Technologies Inc TYME.O :
* SYROS TO RAISE APPROXIMATELY $190 MILLION THROUGH MERGER
WITH
TYME TECHNOLOGIES AND CONCURRENT PRIVATE PLACEMENT
* TYME TECHNOLOGIES INC - SYROS EXPECTS TO HAVE CASH INTO
2025; AT
LEAST A YEAR PAST SELECT-MDS-1 PIVOTAL DATA
* TYME TECHNOLOGIES INC - COMBINED COMPANY WILL OPERATE AS
SYROS
PHARMACEUTICALS AND CONTINUE TO ADVANCE SYROS' ONGOING CLINICAL
PROGRAMS
* TYME TECHNOLOGIES INC - NOW PLANNING TO INITIATE PHASE 3
CLINICAL TRIAL OF SY-2101 IN APL 2H 2023
Source text for Eikon: ID:nBwbrfpgCa
Further company coverage: TYME.O
((Reuters.Briefs@thomsonreuters.com;))